VICTORY CAPITAL MANAGEMENT INC

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1040188 San Antonio, TX

Position in CTMX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$72,397

+$1,141 QoQ

Shares Held

19,306

+27.3% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#133

of 178 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. CTMX ranks #128 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,173,152	$1,079,469,792
2	RPRX	Royalty Pharma plc	3,682,932	$206,501,997
3	INCY	Incyte Corp	1,480,342	$167,811,569
4	JAZZ	Jazz Pharmaceuticals plc	686,719	$165,478,677
5	LGND	Ligand Pharmaceuticals Inc	253,764	$80,212,262
6	REGN	Regeneron Pharmaceuticals, Inc.	126,343	$78,779,914
7	ALNY	Alnylam Pharmaceuticals, Inc.	172,842	$52,030,627
8	BNTX	BioNTech SE	539,787	$50,227,180

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$72,397	19,306	+27.3%	Shares	Sole	2026-08-07
2026-03-31	$71,256	15,161	+3.0%	Shares	Sole	2026-05-15
2025-12-31	$62,715	14,722	+4.3%	Shares	Sole	2026-02-13
2025-09-30	$45,045	14,121	+13.6%	Shares	Sole	2025-11-12
2025-06-30	$28,227	12,435	-99.6%	Shares	Sole	2025-08-13
2021-09-30	$16,639,779	3,269,112	+13.9%	Shares	Sole	2021-11-02
2021-06-30	$18,160,680	2,868,986	+3.6%	Shares	Other	2021-08-03
2021-03-31	$21,403,457	2,768,882	+19.5%	Shares	Sole	2021-05-04
2020-12-31	$15,178,949	2,317,397	-4.5%	Shares	Other	2021-02-01
2020-09-30	$16,144,909	2,427,806	+6.6%	Shares	Sole	2020-11-09
2020-06-30	$18,967,076	2,276,960	-17.9%	Shares	Sole	2020-08-07
2020-03-31	$21,264,507	2,772,426	—	Shares	Sole	2020-05-04
No filing history on record for this holder in this stock.